Machine Learning Helps Predict Risk of Heart Failure
Heart failure is a common complication in patients suffering from Type 2 Diabetes (T2D). Recently, new medicines have been developed to offset... Read more
#ESCCongress: PURE Findings Show CV Events Are Explained by Risk Factors
Late breaking results from the 21-country PURE study were presented at the ESC Congress 2019 this week. The findings are published in The... Read more
#ESCCongress: Artificial Intelligence for Heart Attack Prediction
New findings presented at the ESC Congress in Paris demonstrated technology that uses artificial intelligence (AI) to identify people at high... Read more
Prof. Mamas A Mamas is a structural interventional cardiologist, treating patients with underlying coronary artery with percutaneous coronary intervention (PCI) in both the elective and emergency setting and undertaking Transcatheter Aortic Valve Interventions (TAVI). He is also the Associate Editor of Circulation Cardiovascular Interventions and leads... Read more
Chelsea Beecher serves as the Director of Development for the American Heart & Stroke Association in New York City. She led the launch of STEM Goes Red in New York City and received the Innovator of the Year Award in 2018 for this initiative. STEM Goes Red aims to empower young women to pursue science, technology, engineering, and math (STEM)... Read more
Robots were first used in cardiovascular medicine in the late 1990s as a part of the digital revolution . Since then, robotics have been applied to endovascular surgery, minimally invasive cardiac surgery, and interventional cardiology, to name a few fields. Robots give medical professionals the ability to diagnose, treat, and intervene more... Read more
Integrated, risk-based care for South Africa: Intercare Group focuses on value and innovation
Primary care and wellness centres, dedicated units for sub-acute care... Read more
The Affidea Effect: A Global Dose Data Management System
As the biggest independent provider of advanced diagnostic imaging services... Read more
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...